| scholarly article | Q13442814 |
| P2093 | author name string | Xian-Ming Mo | |
| Jian-Kun Hu | |||
| Kun Yang | |||
| Wei-Han Zhang | |||
| Xiao-Long Chen | |||
| Zong-Guang Zhou | |||
| Zheng-Hao Lu | |||
| Yu-Xin Liu | |||
| Yi-Gao Wang | |||
| Li-Fei Sun | |||
| Pei-Xian Hou | |||
| P2860 | cites work | HER2 heterogeneity in gastric/gastroesophageal cancers: From benchside to practice | Q26741253 |
| Serum HER2 Is a Potential Surrogate for Tissue HER2 Status in Gastric Cancer: A Systematic Review and Meta-Analysis | Q26796280 | ||
| Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial | Q27851578 | ||
| HER2 aberrations and heterogeneity in cancers of the digestive system: Implications for pathologists and gastroenterologists | Q28078111 | ||
| Cell-of-Origin of Cancer versus Cancer Stem Cells: Assays and Interpretations | Q28080701 | ||
| Reduction of miR‑132‑3p contributes to gastric cancer proliferation by targeting MUC13. | Q33671632 | ||
| Serum HER2 levels and HER2 status in tumor cells in advanced gastric cancer patients. | Q53005714 | ||
| Unravelling cancer stem cell potential. | Q53089167 | ||
| Evaluation of serum HER2-ECD levels in patients with gastric cancer. | Q54375870 | ||
| Impact of expression of human epidermal growth factor receptors EGFR and ERBB2 on survival in stage II/III gastric cancer. | Q54483761 | ||
| Prognostic implications of altered human epidermal growth factor receptors (HERs) in gastric carcinomas: HER2 and HER3 are predictors of poor outcome. | Q54578578 | ||
| Prognostic implications of HER2 heterogeneity in gastric cancer. | Q55261916 | ||
| ErbB1 and ErbB3 co-over expression as a prognostic factor in gastric cancer | Q60915179 | ||
| Surgical treatment of gastric cancer: 15-year follow-up results of the randomised nationwide Dutch D1D2 trial | Q62628533 | ||
| Clinical impact of intratumoral HER2 heterogeneity on trastuzumab efficacy in patients with HER2-positive gastric cancer. | Q64938836 | ||
| Japanese classification of gastric carcinoma: 3rd English edition | Q84106763 | ||
| HER2 heterogeneity is a poor prognosticator for HER2-positive gastric cancer | Q92685589 | ||
| The oncogene HER2: its signaling and transforming functions and its role in human cancer pathogenesis | Q34493341 | ||
| Trastuzumab increases the sensitivity of HER2-amplified human gastric cancer cells to oxaliplatin and cisplatin by affecting the expression of telomere-associated proteins | Q34993878 | ||
| Identification and expansion of cancer stem cells in tumor tissues and peripheral blood derived from gastric adenocarcinoma patients | Q35958829 | ||
| Association of HER2 status with prognosis in gastric cancer patients undergoing R0 resection: A large-scale multicenter study in China | Q37012387 | ||
| HER2 in gastric cancer: a new prognostic factor and a novel therapeutic target | Q37149210 | ||
| Serum HER2 as a predictive biomarker for tissue HER2 status and prognosis in patients with gastric cancer | Q37703506 | ||
| Prognostic role of human epidermal growth factor receptor in gastric cancer: a systematic review and meta-analysis | Q38122908 | ||
| Targeting Cancer Stem Cells: Promises and Challenges | Q38548009 | ||
| Akt/AMPK/mTOR pathway was involved in the autophagy induced by vitamin E succinate in human gastric cancer SGC-7901 cells | Q38735041 | ||
| Proliferation, survival and metabolism: the role of PI3K/AKT/mTOR signalling in pluripotency and cell fate determination. | Q38941897 | ||
| Cancer stem cells: The root of tumor recurrence and metastases. | Q39160322 | ||
| Inhibition of the mTOR/S6K signal is necessary to enhance fluorouracil-induced apoptosis in gastric cancer cells with HER2 amplification | Q39344908 | ||
| Quercetin induces protective autophagy in gastric cancer cells: involvement of Akt-mTOR- and hypoxia-induced factor 1α-mediated signaling | Q39536860 | ||
| Cancer statistics in China, 2015. | Q40064386 | ||
| HER-2/neu signal transduction in human breast and ovarian cancer | Q41328221 | ||
| Systems analysis of drug-induced receptor tyrosine kinase reprogramming following targeted mono- and combination anti-cancer therapy. | Q42109090 | ||
| Adjuvant capecitabine plus oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): 5-year follow-up of an open-label, randomised phase 3 trial | Q42695547 | ||
| Identification of novel nuclear localization signal within the ErbB-2 protein | Q46620175 | ||
| CUL4B promotes gastric cancer invasion and metastasis-involvement of upregulation of HER2. | Q47438222 | ||
| Multifunctional nanoparticles for co-delivery of paclitaxel and carboplatin against ovarian cancer by inactivating the JMJD3-HER2 axis. | Q47744129 | ||
| Evaluation of short-term effectiveness of eight targeted agents combined with chemotherapy for treating esophageal-gastric junction adenocarcinoma: A network meta-analysis. | Q48124426 | ||
| A meta-analysis of clinical trials over regimens with or without cetuximab for advanced gastric cancer patients | Q49858846 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P921 | main subject | neoplastic stem cells | Q1638475 |
| P304 | page(s) | 1608 | |
| P577 | publication date | 2020-08-21 | |
| P1433 | published in | Frontiers in Oncology | Q26839986 |
| P1476 | title | The Role of HER2 in Self-Renewal, Invasion, and Tumorigenicity of Gastric Cancer Stem Cells | |
| P478 | volume | 10 |
Search more.